
Opinion|Videos|January 27, 2025
Assessing Symptoms, Treatment Decision-Making, and Monitoring
Panelists discuss when to adjust the dosage of current therapies like sertraline vs considering alternative treatments and the factors that guide these decisions, as well as whether treatments with rapid onset, such as zuranolone capsules or brexanolone intravenous (IV) infusion, would be appropriate for cases like Sarah’s, and what factors would influence the choice between these options.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
4
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
5








